Pre-clinical pipeline expanded with novel wholly-owned candidates PN-477, an oral and s.c. triple GLP-GIP-GCG agonist and PN-458, an oral and s.c. dual GLP-GIP agonist, and PN-8047, an oral hepcidin ...
NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...
BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women. METHODS: Using historical ...
Newcastle race into two-goal lead on the night following close-range efforts from Sandro Tonali and Joelinton Camilo Duran pulls one back for Qarabag with fine finish after the break before Sven ...
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
A woman in her late 20s presented with a 5-year history of progressive fatigue and generalised weakness. Examination revealed signs of premature ageing, anaemia, neuropathy and hepatosplenomegaly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results